Cargando…
Retinal Function and Morphology in the Rabbit Eye after Intravitreal Injection of the TNF Alpha Inhibitor Adalimumab
AIM: To study the effects of the tumor necrosis factor alpha inhibitor adalimumab on rabbit retina after injection into the vitreous body. METHODS: Forty-eight rabbits of mixed strain (9–12 months old, weighing ≈ 3.5 kg) were randomized into four groups. Adalimumab was injected at one of two concent...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Informa Healthcare USA, Inc.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4238743/ https://www.ncbi.nlm.nih.gov/pubmed/24897597 http://dx.doi.org/10.3109/02713683.2014.898309 |
_version_ | 1782345504440451072 |
---|---|
author | Myers, Anna Cardiakidis Ghosh, Fredrik Andréasson, Sten Ponjavic, Vesna |
author_facet | Myers, Anna Cardiakidis Ghosh, Fredrik Andréasson, Sten Ponjavic, Vesna |
author_sort | Myers, Anna Cardiakidis |
collection | PubMed |
description | AIM: To study the effects of the tumor necrosis factor alpha inhibitor adalimumab on rabbit retina after injection into the vitreous body. METHODS: Forty-eight rabbits of mixed strain (9–12 months old, weighing ≈ 3.5 kg) were randomized into four groups. Adalimumab was injected at one of two concentrations (1.25 mg or 2.5 mg) into the eyes of two groups, and balanced salt solution into the eyes of the third group. The fourth group acted as controls. Full-field electroretinography (ffERG) was performed before injection and 1 and 6 weeks post-injection. At 6 weeks post-injection the rabbits were euthanized and the sectioned retinas were studied. Retinal histology was studied with hematoxylin–eosin staining. Immunohistochemical analysis was performed on rods, cones, rod bipolar cells, horizontal cells, amacrine cells and Müller cells. RESULTS: No significant difference in ffERG amplitudes or implicit times was observed between the four groups at any time point. Histological and immunohistochemical findings were similar in all groups. CONCLUSIONS: Injection of adalimumab into the vitreous body of healthy rabbits, at doses up to 2.5 mg, does not appear to be toxic to the rabbit retina. |
format | Online Article Text |
id | pubmed-4238743 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Informa Healthcare USA, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-42387432014-11-25 Retinal Function and Morphology in the Rabbit Eye after Intravitreal Injection of the TNF Alpha Inhibitor Adalimumab Myers, Anna Cardiakidis Ghosh, Fredrik Andréasson, Sten Ponjavic, Vesna Curr Eye Res Original Article AIM: To study the effects of the tumor necrosis factor alpha inhibitor adalimumab on rabbit retina after injection into the vitreous body. METHODS: Forty-eight rabbits of mixed strain (9–12 months old, weighing ≈ 3.5 kg) were randomized into four groups. Adalimumab was injected at one of two concentrations (1.25 mg or 2.5 mg) into the eyes of two groups, and balanced salt solution into the eyes of the third group. The fourth group acted as controls. Full-field electroretinography (ffERG) was performed before injection and 1 and 6 weeks post-injection. At 6 weeks post-injection the rabbits were euthanized and the sectioned retinas were studied. Retinal histology was studied with hematoxylin–eosin staining. Immunohistochemical analysis was performed on rods, cones, rod bipolar cells, horizontal cells, amacrine cells and Müller cells. RESULTS: No significant difference in ffERG amplitudes or implicit times was observed between the four groups at any time point. Histological and immunohistochemical findings were similar in all groups. CONCLUSIONS: Injection of adalimumab into the vitreous body of healthy rabbits, at doses up to 2.5 mg, does not appear to be toxic to the rabbit retina. Informa Healthcare USA, Inc. 2014-11 2014-06-04 /pmc/articles/PMC4238743/ /pubmed/24897597 http://dx.doi.org/10.3109/02713683.2014.898309 Text en © 2014 Informa Healthcare USA, Inc. All rights reserved: reproduction in whole or part not permitted http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the CC-BY-NC-ND 3.0 License which permits users to download and share the article for non-commercial purposes, so long as the article is reproduced in the whole without changes, and provided the original source is credited. |
spellingShingle | Original Article Myers, Anna Cardiakidis Ghosh, Fredrik Andréasson, Sten Ponjavic, Vesna Retinal Function and Morphology in the Rabbit Eye after Intravitreal Injection of the TNF Alpha Inhibitor Adalimumab |
title | Retinal Function and Morphology in the Rabbit Eye after Intravitreal Injection of the TNF Alpha Inhibitor Adalimumab |
title_full | Retinal Function and Morphology in the Rabbit Eye after Intravitreal Injection of the TNF Alpha Inhibitor Adalimumab |
title_fullStr | Retinal Function and Morphology in the Rabbit Eye after Intravitreal Injection of the TNF Alpha Inhibitor Adalimumab |
title_full_unstemmed | Retinal Function and Morphology in the Rabbit Eye after Intravitreal Injection of the TNF Alpha Inhibitor Adalimumab |
title_short | Retinal Function and Morphology in the Rabbit Eye after Intravitreal Injection of the TNF Alpha Inhibitor Adalimumab |
title_sort | retinal function and morphology in the rabbit eye after intravitreal injection of the tnf alpha inhibitor adalimumab |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4238743/ https://www.ncbi.nlm.nih.gov/pubmed/24897597 http://dx.doi.org/10.3109/02713683.2014.898309 |
work_keys_str_mv | AT myersannacardiakidis retinalfunctionandmorphologyintherabbiteyeafterintravitrealinjectionofthetnfalphainhibitoradalimumab AT ghoshfredrik retinalfunctionandmorphologyintherabbiteyeafterintravitrealinjectionofthetnfalphainhibitoradalimumab AT andreassonsten retinalfunctionandmorphologyintherabbiteyeafterintravitrealinjectionofthetnfalphainhibitoradalimumab AT ponjavicvesna retinalfunctionandmorphologyintherabbiteyeafterintravitrealinjectionofthetnfalphainhibitoradalimumab |